PDCD1LG2 and neoplasm: Inhibition of PD-1 probably affects peripheral interactions as well, through PD-L2 on APCs, but it might act more locally at tumor sites through blocking the interaction of PD-L1 on tumor cells with PD-1 in tumor-infiltrating T cells.